Sarcoidosis
Therapeutic area
Rheumatology
Rare disease
Yes
- Definition
- Sarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Sarcoidosis
- Therapeutic area
- Rheumatology
- sarcoidosis
- Besnier-Boeck-Schaumann disease
- Boeck sarcoid
- Boeck's sarcoid
- Boeck's sarcoidosis
- Darier-Roussy sarcoid
- besnier-Boeck-Schaumann syndrome
- sarcoid
- sarcoidosis
- Disease mechanisms
- Syndromic
- All therapeutic areas
- Rheumatology
- Severity
- Severe
- MONDO ID
- MONDO:0019338
- Parent condition
- MONDO:0019751
Related records
Broader conditions (7)
- Autoinflammatory syndrome
- Connective tissue disorder
- Disease
- Disease by body system or component
- Human disease
- Rheumatic disorder
- Syndromic disease
Narrower conditions (9)
- Blau syndrome
- Cardiac sarcoidosis
- Cerebral sarcoidosis
- Hypercalcemic sarcoidosis
- Löfgren syndrome
- Neurosarcoidosis
- Pulmonary sarcoidosis
- Skin sarcoidosis
- Uveoparotid fever
Trials (246)
- A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
- A Clinical Study of Tranilast in the Treatment of Sarcoidosis
- A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)
- A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid
- A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
- A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques
- A Phase 2 Study With CC-220 in Skin Sarcoidosis
- A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis
- A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag
- A Study of Adalimumab to Treat Sarcoidosis of the Skin
- A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
- A Study of Infliximab in Patients With Sarcoidosis
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis
- A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
- A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis
- A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus
- A Trial of Baricitinib in Patients With Cardiac Sarcoidosis
- A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of Sarcoidosis
Approved drugs (4)
- Dexamethasone
- Dexamethasone sodium phosphate
- Prednisolone
- Prednisone
Drugs in development (31)
- Abatacept Phase 2
- Abrocitinib Phase 2
- Adalimumab Phase 2
- Atorvastatin Phase 2
- Avotermin Phase 3
- Azithromycin Phase 2
- Cibinetide Phase 2
- Corticotropin Phase 2
- Cyclophosphamide Phase 2
- Dapsone Phase 2
- Ensereptide Phase 2
- Ethambutol Phase 2
- Golimumab Phase 2
- Iberdomide Phase 2
- Iberdomide hydrochloride Phase 2
- Ilodecakin Phase 2
- Infliximab Phase 3
- Levofloxacin Phase 2
- Mannose 6-phosphate Phase 2
- Metformin Phase 2
Other linked drugs (2)
- Collagenase clostridium histolyticum
- Maraviroc